Implementation of Percutaneous Coronary Intervention During the COVID-19 Pandemic in Japan - Nationwide Survey Report of the Japanese Association of Cardiovascular Intervention and Therapeutics for Cardiovascular Disease -
Implementation of Percutaneous Coronary Intervention During the COVID-19 Pandemic in Japan - Nationwide Survey Report of the Japanese Association of Cardiovascular Intervention and Therapeutics for Cardiovascular Disease -
复制标题
DOI：
10.1253/circj.cj-20-0708
复制
发表时间：
2020-12-01
影响因子：
3.3
通讯作者：
Ikari, Yuji
中科院分区：
文献类型：
--
作者：
Ishii, Hideki;Amano, Tetsuya;Ikari, Yuji
背景：随着COVID-19的快速传播，提供经皮冠状动脉介入治疗（PCI）的医院处于独特而陌生的环境。本研究根据日本COVID-19大流行的时间进程评估了冠状动脉疾病治疗的变化。方法和结果：日本心血管干预和治疗协会在大流行期间（2020年4月中旬、4月下旬和5月中旬）进行了系列调查，询问了有关PCI实施的问题。医院被问及他们对st段抬高型心肌梗死（STEMI）和高危急性冠脉综合征（ACS）患者的选择性PCI和急诊PCI的治疗策略。在大流行开始时，大多数医院选择以通常的方式进行初级PCI。随着疫情的发展，7个人口稠密地区的医院降低了慢性冠脉综合征和高危ACS患者的PCI治疗效果，但STEMI患者没有降低PCI治疗效果。5月中旬大多数县解除紧急状态后，PCI率逐渐恢复正常。筛查试验，如聚合酶链反应和胸部计算机断层扫描，在ACS常用。结论：新冠肺炎疫情对日本PCI治疗影响较大。然而，即使在大流行期间最危急的情况下，大多数机构继续对STEMI患者正常进行初级PCI治疗。
Background: With the rapid spread of COVID-19, hospitals providing percutaneous coronary intervention (PCI) were placed in unique and unfamiliar circumstances. This study evaluated variations in the treatment of coronary artery disease according to time course of the COVID-19 pandemic in Japan.Methods and Results: The Japanese Association of Cardiovascular Intervention and Therapeutics performed serial surveys during the pandemic (in mid-April, late-April and mid-May 2020) with queries regarding the implementation of PCI. Hospitals were asked about their treatment strategies for elective PCI and emergency PCI for ST-elevation myocardial infarction (STEMI) and high-risk acute coronary syndrome (ACS) patients. Most hospitals opted to perform primary PCI in the usual manner at the beginning of the pandemic. As the pandemic progressed, hospitals in the 7 populated areas downgraded the performance of PCI for chronic coronary syndrome and high-risk ACS, but not for STEMI patients. After the state of emergency was lifted in most prefectures in mid-May, the rate of PCI gradually normalized. Screening tests, such as polymerase chain reaction and chest computed tomography, in ACS were frequently used.Conclusions: The COVID-19 pandemic greatly affected PCI treatment in Japan. However, even in the most critical situations during the pandemic, most institutions continued to perform primary PCI normally for STEMI patients.